Form 8-K - Current report:
SEC Accession No. 0000886163-17-000077
Filing Date
2017-06-01
Accepted
2017-05-31 17:49:35
Documents
1
Period of Report
2017-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k-aziyobio8k.htm 8-K 27313
  Complete submission text file 0000886163-17-000077.txt   28461
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 17882591
SIC: 2834 Pharmaceutical Preparations